National Centre for the Development of Gene Therapy and RNA Technology Medicines

The Foundation conducts research in areas of strategic importance for the production of therapies or the design of procedures for human health, integrating the development of therapies with their targeted delivery. Its aim is to create and renew research infrastructures and laboratories, and to establish and develop research programmes and activities to foster the creation and growth of entrepreneurial initiatives with a higher technological content and to enhance the value of research results in the specified fields.
The Foundation, for which the University of Padua is the proposing and lead institution, involves 49 entities including universities, public research bodies, private organisations and companies.
Theme: Development of gene therapy and RNA technology-based medicines
Unipd project contact: Rosario Rizzuto
Proposing entity: University of Padua
Implementing entity: Centro Nazionale sullo sviluppo di terapia genica e farmaci con tecnologia RNA
Website: https://www.rna-genetherapy.eu/
- University of Padua
- Consiglio Nazionale delle Ricerche
- Humanitas University
- Istituto Italiano di Tecnologia
- Ospedale Pediatrico Bambino Gesù
- Fondazione Ri.MED
- University Magna Grecia
- University of Bari
- University of Bologna
- University of Brescia
- University of Cagliari
- University of Campania – Vanvitelli
- University G. D'Annunzio
- University of Catania
- University of Firenze
- University of Milano
- University of Milano-Bicocca
- University of Modena e Reggio Emilia
- University of Napoli Federico II
- University of Palermo
- University of Pisa
- University of Pavia
- Sapienza University of Roma
- University of Roma Tor Vergata
- University of Salerno
- University of Siena
- University Vita-Salute San Raffaele
- University of Torino
- University of Trieste
- University of Verona
- Fondazione Tettamanti
- Fondazione Telethon
- Dompè Farmaceutici SpA
- Takis Biotech Srl
- Chiesi Farmaceutici SpA
- Eurofins Biolab Srl
- Novartis International AG
- Pfizer INC
- Stevanato Group SpA
- PBL Srl
- Innovavector Srl
- Sanofi
- Astrazeneca
- Bracco SpA
- BioNTech
- Antares Vision Group Spa
- Orgenesis Italy Srl
- IRBM SpA
- Intesa Sanpaolo Spa
VIDEO: Rosario Rizzuto presents the National Centre for the development of gene therapy and RNA technology medicines in the Agorà delle Scienze of Science4All 2025
